Quality of life · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Social and occupational functioning · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · participants with depressive or anxiety disorders
It is very uncertain whether abrupt discontinuation changes adverse events compared with continuation of long‐term antidepressants (very low certainty).
1 finding from 1 review
Depressive symptoms · participants with depressive or anxiety disorders
1 finding from 1 review
Anxiety · participants with depressive or anxiety disorders
1 finding from 1 review
Quality of life · participants with depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Social and occupational functioning · participants with depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Successful discontinuation rate · participants with depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
MST vs ECT ‐ symptom severity ‐ HAMD (high = poor; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ cognitive function ‐ immediate memory (high = better; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ cognitive function ‐ delayed memory (high = better; short term) · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ suicides, suicide attempts, self‐harm · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
MST vs ECT ‐ quality of life · patients with schizophrenia
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ social functioning · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
MST vs ECT ‐ dropout for any reason (short term) · patients with schizophrenia
It is very uncertain whether the intervention changes MST vs ECT ‐ dropout for any reason (short term) (very low certainty).
1 finding from 1 review
Intervention not reported
MST vs ECT ‐ serious adverse events · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
MST vs ECT ‐ adverse events that led to discontinuation of treatment (short term) · patients with schizophrenia
1 finding from 1 review
Depression response (acute phase, 5 ≤ 12 weeks) · women of any age, with PND up to 12 months
Antidepressants showed no clear difference in depression response (acute, 5 ≤ 12 weeks) compared with placebo (low certainty).
1 finding from 1 review
RR 1.27 [0.97, 1.66]
Studies not reported
Low
Depression remission · women of any age, with PND up to 12 months
It is very uncertain whether antidepressants changes depression remission (early phase, < 5 weeks) compared with treatment (very low certainty).
1 finding from 1 review
RR 2.31 [1.5, 3.54]
Studies not reported
Very low
Depression severity ‐ mean EPDS score (early phase, < 5 weeks) · women of any age, with PND up to 12 months
1 finding from 1 review
no estimate extracted
Studies not reported
Very low